Improved screening means new targets for pediatric neuroblastoma therapies
- OPACC
- Mar 4, 2014
- 1 min read
Neuroblastoma is one of the most common and lethal types of childhood cancers. In a paper published online today in OncoTarget, a researcher at the University of Texas Health Science Center at San Antonio unveils the important role of microRNAs in regulating neuroblastoma development, pointing to new therapeutic possibilities.
Comments